Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Decade in review-multiple sclerosis: New drugs and personalized medicine for multiple sclerosis.
Low-level laser therapy ameliorates disease progression in a mouse model of multiple sclerosis.
Delayed initial recovery and long lie following a fall among middle-aged and older adults with multiple sclerosis.
Molecular pathogenesis of neuromyelitis optica.
Blocking A2B Adenosine Receptor Alleviates Pathogenesis of Experimental Autoimmune Encephalomyelitis via Inhibition of IL-6 Production and Th17 Differentiation.
Value of the MoCA Test as a Screening Instrument in Multiple Sclerosis.
[Retinal vasculitis as manifestation of multiple sclerosis.]
Health care-resource utilization before and after natalizumab initiation in multiple sclerosis patients in the US.
Potassium channel KIR4.1-specific antibodies in children with acquired demyelinating CNS disease.
Multiple sclerosis care in Latin America.
Loss of striatal type 1 cannabinoid receptors is a key pathogenic factor in Huntington's disease.
An update on new and emerging therapies for relapsing-remitting multiple sclerosis.
No association between CCL2 gene polymorphisms and risk of inflammatory demyelinating diseases in a Korean population.
Music mnemonics aid Verbal Memory and Induce Learning - Related Brain Plasticity in Multiple Sclerosis.
Notable Increased Cerebrospinal Fluid Levels of Soluble Interleukin-6 Receptors in Neuromyelitis Optica.
Cognitive deficit is related to immune-cell beta-NGF in multiple sclerosis patients.
Positive Effect on Multiple Sclerosis With Treatment of Metabolic Syndrome.
Voltage-gated potassium channel antibodies: Game over.
Nature plus nurture: the triggering of multiple sclerosis.
The multiple sclerosis depression rating scale.
Rituximab combination therapy in relapsing multiple sclerosis.
Sphingosine-1-Phosphate Links Persistent STAT3 Activation, Chronic Intestinal Inflammation, and Development of Colitis-Associated Cancer.
Determining the Presence of Reliable Change over Time in Multiple Sclerosis: Evidence from the PASAT, Adjusting-PSAT, and Stroop Test.
Multiple sclerosis: managing a complex neurological disease.
Increasing serum levels of vitamin A, D and E are associated with alterations of different inflammation markers in patients with multiple sclerosis.

Pages